Cita APA (7a ed.)

Urru, S. A. M., Alegiani, S. S., Guella, A., Traversa, G., & Campomori, A. (2021). Safety of switching between rituximab biosimilars in onco-hematology. Nature Portfolio.

Cita Chicago Style (17a ed.)

Urru, Silvana A. M., Stefania Spila Alegiani, Anna Guella, Giuseppe Traversa, y Annalisa Campomori. Safety of Switching Between Rituximab Biosimilars in Onco-hematology. Nature Portfolio, 2021.

Cita MLA (8a ed.)

Urru, Silvana A. M., et al. Safety of Switching Between Rituximab Biosimilars in Onco-hematology. Nature Portfolio, 2021.

Precaución: Estas citas no son 100% exactas.